Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Completed1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Research Network

Collaboration Network

25 collaborators·50 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Hospital del Mar

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Emilio Montserrat, MD

Clinic Hospital Universitari, Hematology. Barcelona

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Werner Dolak, MD

Medical University of Vienna, Department of Internal Medicine III, Division of Gastroenterologie and Hepatologie

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Giovanni Martinelli, MD

Hemato-oncology. European Oncology Institute. Milan

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Maurizio Martelli, MD

Hematology. Università La Sapienza. Roma

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Stephen J Schuster, MD

University of Pennsylvania

Moderately Similar
2 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Emanuele Zucca, MD

International Extranodal Lymphoma Study Group/Oncology Institute of Southern Switzerland. Bellinzona

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Catherine Thieblemont, MD

Centre Hospitalier Lyon Sud, Hematology. Lyon

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Claudio Brunstein, MD, PhD

Masonic Cancer Center, University of Minnesota

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Peter Johnson, MD

Oncology Unit. Southampton General Hospital. Southampton

Moderately Similar
1 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Ning Li, Ph.D

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Moderately Similar
3 trials

Shared therapeutic areas:

Lymphoma, B-Cell, Marginal Zone
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01015248Phase 2PrincipalInvestigator

Trial of Bendamustine And Rituximab for Patients With Previously Untreated Extranodal Mucosa-Associated Lymphoid Tissue (MALT) Lymphoma

MALT LYMPHOMA
Completed

All 1 trials loaded